Why Investors Shouldn't Be Surprised By GPI S.p.A.'s (BIT:GPI) P/E
Jan 24
Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedJan 24, 2026
DataAggregated Company Financials
Companies18
- 7D-1.1%
- 3M-7.2%
- 1Y-21.1%
- YTD0.09%
Over the last 7 days, the Healthcare industry has dropped 1.1%, driven by Recordati Industria Chimica e Farmaceutica declining 2.3%. Overall the industry is down 21% in 12 months. As for the next few years, earnings are expected to grow by 11% per annum.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 25 Jan 2026 | €20.8b | €8.8b | €886.9m | 21.4x | 23.5x | 2.4x |
| Tue, 23 Dec 2025 | €20.8b | €8.8b | €886.9m | 20.7x | 23.4x | 2.4x |
| Thu, 20 Nov 2025 | €20.3b | €8.8b | €887.5m | 18.5x | 22.8x | 2.3x |
| Sat, 18 Oct 2025 | €22.2b | €8.8b | €896.1m | 20.5x | 24.8x | 2.5x |
| Mon, 15 Sep 2025 | €22.8b | €8.7b | €894.6m | 20x | 25.5x | 2.6x |
| Wed, 13 Aug 2025 | €22.2b | €8.7b | €902.9m | 19.5x | 24.6x | 2.6x |
| Fri, 11 Jul 2025 | €24.7b | €8.6b | €941.3m | 20.1x | 26.3x | 2.9x |
| Sun, 08 Jun 2025 | €23.9b | €25.2b | €985.5m | 19.6x | 24.2x | 0.9x |
| Tue, 06 May 2025 | €23.0b | €20.1b | €906.9m | 18.5x | 25.4x | 1.1x |
| Thu, 03 Apr 2025 | €22.3b | €20.0b | €831.7m | 16.5x | 26.8x | 1.1x |
| Sat, 01 Mar 2025 | €24.8b | €20.0b | €821.4m | 23.3x | 30.1x | 1.2x |
| Mon, 27 Jan 2025 | €25.5b | €7.9b | €829.1m | 23.3x | 30.8x | 3.2x |
| Wed, 25 Dec 2024 | €24.3b | €18.7b | €1.4b | 21x | 17.1x | 1.3x |
| Fri, 22 Nov 2024 | €24.3b | €19.0b | €1.4b | 19.2x | 17x | 1.3x |
| Sun, 20 Oct 2024 | €26.0b | €18.9b | €1.4b | 18.1x | 18.8x | 1.4x |
| Tue, 17 Sep 2024 | €25.1b | €18.9b | €1.4b | 16.7x | 18x | 1.3x |
| Thu, 15 Aug 2024 | €25.1b | €18.9b | €1.4b | 16.4x | 18.1x | 1.3x |
| Sat, 13 Jul 2024 | €26.1b | €18.8b | €1.4b | 17.3x | 18.8x | 1.4x |
| Mon, 10 Jun 2024 | €26.5b | €18.8b | €1.4b | 17.2x | 19.1x | 1.4x |
| Wed, 08 May 2024 | €26.2b | €18.7b | €1.4b | 19.5x | 18.9x | 1.4x |
| Fri, 05 Apr 2024 | €25.1b | €18.7b | €1.4b | 19.7x | 18.2x | 1.3x |
| Sun, 03 Mar 2024 | €25.4b | €18.6b | €1.4b | 18.4x | 18.1x | 1.4x |
| Tue, 30 Jan 2024 | €24.5b | €18.6b | €1.4b | 19x | 17.6x | 1.3x |
| Thu, 28 Dec 2023 | €24.8b | €18.6b | €1.4b | 18.5x | 17.8x | 1.3x |
| Sat, 25 Nov 2023 | €23.1b | €18.6b | €1.4b | 18.5x | 16.5x | 1.2x |
| Mon, 23 Oct 2023 | €22.2b | €18.6b | €1.4b | 16.3x | 15.4x | 1.2x |
| Wed, 20 Sep 2023 | €23.2b | €17.3b | €1.1b | 16.3x | 20.4x | 1.3x |
| Fri, 18 Aug 2023 | €23.3b | €7.8b | €856.3m | 18.2x | 27.2x | 3x |
| Sun, 16 Jul 2023 | €23.6b | €7.7b | €822.5m | 16.3x | 28.7x | 3.1x |
| Tue, 13 Jun 2023 | €25.0b | €7.7b | €822.5m | 19.6x | 30.4x | 3.2x |
| Thu, 11 May 2023 | €24.9b | €7.6b | €825.6m | 22.5x | 30.1x | 3.3x |
| Sat, 08 Apr 2023 | €23.4b | €7.5b | €823.6m | 21.6x | 28.4x | 3.1x |
| Mon, 06 Mar 2023 | €24.0b | €7.5b | €867.3m | 25x | 27.6x | 3.2x |
| Wed, 01 Feb 2023 | €23.2b | €7.4b | €886.1m | 22.4x | 26.2x | 3.1x |
Price to Earnings Ratio
26.2x
Current Industry PE
- Investors are relatively neutral on the Italian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 22.8x.
- The 3-year average PS ratio of 1.9x is lower than the industry's current PS ratio of 2.4x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.9% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | -1.83% | |
| Healthcare | -1.10% | |
| Healthtech | 10.27% | |
| Life Sciences | 3.96% | |
| Healthcare Services | 1.17% | |
| Medical Equipment | -1.47% | |
| Biotech | -2.11% | |
| Pharma | -2.25% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 55.9x.
- Analysts are expecting annual earnings growth of 24.9%, which is lower than the prior year's growth of 116.9% per year.
- Investors are most pessimistic about the Life Sciences industry, which is trading below its 3-year average of 35.4x.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 25% over the next 5 years.
- However this is lower than its past earnings growth rate of 117% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 76% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AMP Amplifon | €13.91 | 1.9% +€58.3m | -45.8% | PE26.5x | |
| GPI GPI | €17.18 | 10.3% +€46.2m | 68.8% | PE31.3x | |
| FF Fine Foods & Pharmaceuticals N.T.M | €10.25 | 4.0% +€9.5m | 49.0% | PE20x | |
| IVN iVision Tech | €2.54 | 61.8% +€7.7m | 33.0% | PE209.5x | |
| ARBS Arterra Bioscience | €3.32 | 5.7% +€1.2m | 70.3% | PE16.5x |
